Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-26

Clinical Trial Update: OASIS: Osteoarthritis Sensitivity Integration Study [NA]

View source ↗

Summary

The OASIS trial evaluating osteoarthritis sensitivity integration has been withdrawn from the registry. No further development or results are expected.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Osteoarthritis, Chronic Pain | NA | Status: WITHDRAWN